ACE2 and chronic obstructive pulmonary disease: Accumulating evidence reveals that CS exposure upregulates ACE2, and ACE2 has been found to be significantly upregulated in smokers compared with non-smokers, as well as in patients with COPD compared with healthy subjects (20, 31–36).